Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
This protein carries a human IgG1 Fc tag at the N-terminus.
The protein has a calculated MW of 42.3 kDa. The protein migrates as 48-53 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
>90% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
Human TNF-beta Protein, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).
The purity of Human TNF-beta Protein, Fc Tag (Cat. No. TNB-H5263) is more than 85% and the molecular weight of this protein is around 255-285 kDa verified by SEC-MALS.
Immobilized Human TNFR2, His Tag (Cat. No. TN2-H5227) at 5 μg/mL (100 μL/well) can bind Human TNF-beta Protein, Fc Tag (Cat. No. TNB-H5263) with a linear range of 0.2-5 ng/mL (QC tested).
Immobilized Human HVEM, His Tag (Cat. No. HVM-H52E9) at 5 μg/mL (100 μL/well) can bind Human TNF-beta Protein, Fc Tag (Cat. No. TNB-H5263) with a linear range of 0.2-5 ng/mL (Routinely tested).
Explore our catalog of therapeutic antibody solutions to find the right products for you! We are dedicated to delivering solutions designed to help you drive innovation and push the boundaries of what therapeutic antibodies can be.
We offer a wide range of cell and gene therapy solutions starting from discovery to the clinic. Explore our wide range of proteins, antibodies, kits, and other assays to accelerate the development of your cell and gene therapy.
Organoid Toolbox is a collection of organoid solutions including ready-to-use organoids, organoid differentiation kits, and a variety of services to accelerate the progress of your drug development project.
ACROBiosystems developed a series of GMP grade cytokines under the GMP grade quality management system. Those products are all suitable for T/NK cell generation, activation, and proliferation in cell therapy research.
50+ targets designed for CAR detection, including PE/FITC/biotin labeled proteins. The key reagents for CD19 and BCMA were FDA DMF filed which can support your IND, NDA and BLA process.
GMP grade cytokines, reagents for cell activation, gene edition, DNA/RNA removal, etc. Particularly focus on product design, quality control and solution-based support to link each phase of your cell and gene therapy journey.
Full length multi-pass TPs with stabilized structure and high bioactivity for immunization, antibody screening, cell based assay and CAR detection, including hot CD20, Claudin 18.2, CD133, GPRC5D,CCR8, CCR5, etc.
A series of immune checkpoints including classic co-inhibitory and co-stimulatory receptors. The comprehensive catalog contains 100+ targets with various species and tags, and the high-quality proteins are in good batch-to-batch consistency.
To meet the needs of ADCs development, ACROBiosystems can provide: A variety of high-quality target proteins; MMPs/Cathepsin/uPA for cleavable linker; Anti-payload antibodies & anti-idiotypic antibodies for immunogenicity and PK analysis; SPR/BLI analytical and ADA development service.
Comprehensive collection of Fc receptor proteins, including their common variants, which can help expedite your antibody development.
Comprehensive cytokine targets including interleukins, growth factors, chemokines, TNFs, etc. are expressed by HEK293 to ensure their natural structure. Their high purity is verified by SDS-PAGE/HPLC/SEC-MALS and high bioactivity is verified by ELISA/SPR/BLI.
Aneuro provides comprehensive tools for neuroscience research, including neuroscience proteins, pre-formed fibrils (PFFs), neural antibodies, neural factors, and more—aiming to accelerate disease modeling, drug screening, and neural mechanism studies.
English Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Etanercept biosimilar (Hanwha Chemical) | HD-203; MK-8953 | Approved | Hanwha Chemical | Davictrel | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic | Details | ||||
Etanercept biosimilar (AryoGen Biopharma) | Approved | Aryogen Biopharma | Altebrel | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic | Details | |||||
Etanercept biosimilar (Nanogen Biopharmaceutical) | Approved | Nanogen Biopharmaceutical Co | Nanercept | Vietnam | Psoriasis; Arthritis, Rheumatoid | Nanogen Biopharmaceutical Co | 2019-01-01 | Arthritis, Rheumatoid; Psoriasis | Details | |
Etanercept biosimilar (Mochida) | LBEC-0101 | Approved | Mochida Pharmaceutical Co Ltd | Japan | Arthritis, Juvenile; Arthritis, Rheumatoid | null | 2018-01-19 | Arthritis, Rheumatoid; Arthritis, Juvenile | Details | |
Etanercept biosimilar (PROBIOMED) | Approved | Probiomed | Infinitam | Mexico | Arthritis, Rheumatoid | Probiomed | 2014-01-01 | Arthritis, Rheumatoid | Details | |
Etanercept biosimial (Sandoz) | GP-2015 | Approved | Clariant Produkte (Schweiz) Ag | Erelzi | United States | Psoriasis; Arthritis, Juvenile; Arthritis, Rheumatoid; Arthritis, Psoriatic; Spondylitis, Ankylosing | Sandoz | 2016-08-30 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Plaque psoriasis | Details |
Etanercept biosimilar (Amega Biotech) | Approved | Amega Biotech | Enerceptan | Argentina | Arthritis, Rheumatoid | Amega Biotech | 2012-01-01 | Arthritis, Rheumatoid | Details | |
Etanercept biosimilar (Intas Biopharmaceuticals) | Approved | Intas Biopharmaceuticals | Intacept | India | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Juvenile; Arthritis, Rheumatoid; Psoriasis | Intas Biopharmaceuticals | 2015-03-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic | Details | |
Etanercept biosimilar (Mylan) | YLB-113 | Approved | Lupin Ltd, Mylan Nv | Nepexto | EU | Spondylarthropathies; Spondylitis, Ankylosing; Arthritis, Psoriatic; Arthritis, Juvenile; Arthritis, Rheumatoid; Plaque psoriasis | Biosimilar Collaborations Ireland Ltd | 2020-05-20 | Spondylarthropathies; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Juvenile; Arthritis, Psoriatic; Plaque psoriasis | Details |
Etanercept biosimilar (Sunshine Guojian) | 301S | Approved | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd, Cipla Gmbh | Yisaipu, 益赛普, Etanar, Etacept | Mainland China | Arthritis, Rheumatoid; Psoriasis; Spondylitis, Ankylosing | Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd | 2005-06-20 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Details |
Opinercept | E-11; ENIA-11 | Approved | TSH Biopharm Corp Ltd, Mycenax Biotech Inc | TuNEX | Taiwan | Arthritis, Rheumatoid | null | 2017-01-01 | Spondylitis, Ankylosing; Arthritis, Rheumatoid | Details |
Etanercept biosimilar (Reliance Life Sciences) | Approved | Reliance Life Sciences | Arthritis, Rheumatoid | Details | ||||||
Etanercept biosimilar (Hisun-Pfizer Pharmaceuticals) | Approved | Hisun-Pfizer | AnBaiNuo, 安佰诺 | Mainland China | Arthritis, Psoriatic; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis | Wyeth Europa Ltd | 2010-02-26 | Spondylitis, Ankylosing; Arthritis, Rheumatoid; Psoriasis; Arthritis, Psoriatic | Details | |
Etanercept biosimilar (Qilu Pharmaceutical) | QL-0902 | Approved | Qilu Pharmaceutical Co Ltd | Mainland China | Qilu Pharmaceutical Co Ltd | 2023-12-19 | Arthritis, Rheumatoid; Spondylitis, Ankylosing | Details | ||
Etanercept biosimilar (Samsung Bioepis) | SB-4 | Approved | Samsung Bioepis Co Ltd | Eticovo, Benepali | EU | Arthritis, Psoriatic; Arthritis, Rheumatoid; Plaque psoriasis; Spondylitis, Ankylosing | Samsung Bioepis Nl Bv | 2016-01-13 | Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Juvenile; Psoriasis; Arthritis, Psoriatic; Plaque psoriasis | Details |
Etanercept | TNR-001 | Approved | Amgen Inc, Pfizer Inc | Lifmior, 恩利, Enbrel | EU | Arthritis, Juvenile; Plaque psoriasis; Spondylitis, Ankylosing; Arthritis, Rheumatoid; Arthritis, Psoriatic | Pfizer Europe Ma Eeig | 2000-02-02 | Cachexia; Pulmonary Fibrosis; Temporomandibular Joint Disorders; Psoriasis; Myositis, Inclusion Body; Prostatic Neoplasms; Arthritis, Psoriatic; Asthma; Alzheimer Disease; Bone Neoplasms; Lichen Planus; Lung Neoplasms; Respiratory Distress Syndrome, Adult; Arthritis; Uveitis; Inflammation; Hidradenitis Suppurativa; Obesity; Stomatitis; Plaque psoriasis; Acute Lung Injury; Kidney Failure, Chronic; Neoplasm Metastasis; Vitiligo; Anorexia; Solid tumours; Tinnitus; Leukemia; Diabetes Mellitus, Type 1; Granulomatosis with Polyangiitis; HIV Infections; Bronchiolitis Obliterans; Lupus Erythematosus, Discoid; Rejection of lung transplantation; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Non-radiographic axial spondyloarthritis; Lupus Erythematosus, Cutaneous; Sjogren's Syndrome; Synovitis; Metabolic Syndrome; Vasculitis; Spondylarthritis; Chronic Urticaria; Graft vs Host Disease; Fanconi Anemia; Arthritis, Juvenile | Details |
English Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Etanercept Biosimilar (Mabxience Holdings) | MB04; MB-04 | Phase 3 Clinical | Mabxience Holdings SL | Autoimmune Diseases; Arthritis, Rheumatoid | Details |
Etanercept biosimilar (Suzhou Genemen Biotech) | BF-02; GM-02 | Phase 1 Clinical | Suzhou Genemen Biotech Co Ltd | Spondylitis, Ankylosing | Details |
Etanercept biosimilar (Shilpa Biologicals) | SBDM-01 | Phase 1 Clinical | Shilpa Biologicals Pvt Ltd | Polyarticular Juvenile Idiopathic Arthritis; Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Plaque psoriasis | Details |
Etanercept (Neurokine Pharmaceuticals) | NP-1; NK-001 | Clinical | Pivot Pharmaceuticals | Cognition Disorders | Details |
This web search service is supported by Google Inc.